This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Martin-Toutain, I Articles by Ankri, A Search for Related Content PubMed PubMed Citation Articles by Martin-Toutain, I Articles by Ankri, A Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Blood Thinners Hazardous Substances DB HEPARIN Social Bookmarking                         What's this?

Hgh prevalence of antibodies to platelet factor 4 heparin in patients with antiphospholipid antibodies in absence of heparin-induced thrombocytopenia

Service d'Hématologie Biologique Groupe Hospitalier Pitié-Salpêtrière, Paris, France

JC Piette

Service de Médecine Interne Groupe Hospitalier Pitié-Salpêtrière, Paris, France

MC Diemert

Laboratoire d'Immunochimie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France

C Faucher

L Jobic

Service d'Hématologie Biologique Groupe Hospitalier Pitié-Salpêtrière, Paris, France

A Ankri

Service d'Hématologie Biologique Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Service d'Hématologie Biologique, Pavillon Laveran, Groupe Hospitalier Pitié-Salpêtrière, 75013 Paris, France.; annick.ankri{at}psl.ap-hop-paris.fr

Seventy-two patients with antiphospholipid antibodies (aPL), with or without antiphospholipid syndrome (APS), were studied for detection of heparin-PF4-induced antibodies (HPIA) using a commercial kit (Asserachrom^® HPIA) PF4-dependant enzyme-linked immunoassay (ELISA) test. None of the patients had a medical history of heparin induced thrombocytopenia (HIT). Eleven percent of patients were positive for HPIA. Plasma from 40 of the 72 patients (seven positive and 33 negative), was also tested with the other available HPIA ELISA (GTI^®) kit. Five patients were positive with both ELISA kits, two were highly positive only with Asserachrom^® HPIA and four only with GTI^®. None of the positive patients had severe thrombocytopenia. Two patients have never received heparin treatment. No relationship was found between HPIA presence and patients' age, sex, aPL levels or presence of lupus anticoagulant. No significant difference in HPIA presence was observed in patients with primary APS, secondary APS or aPL without APS. We found a poor correlation between the two commercial ELISA showing that, on the same blood sample, a patient could be highly positive with one technique and negative with the other. The PF4-dependant enzyme-linked immunoassay, which is often the first test used for the diagnosis of HIT, should be interpreted cautiously in patients with aPL since there is a danger of overdiagnosis and overtreatment.

Key Words: antiphospholipid antibodies • antiphospholipid syndrome • heparin induced thrombocytopenia • heparin-PF4-induced antibodies

Lupus, Vol. 16, No. 2, 79-83 (2007)
DOI: 10.1177/0961203306075562


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D Alpert, L A Mandl, D Erkan, W Yin, E I Peerschke, and J E Salmon Anti-heparin platelet factor 4 antibodies in systemic lupus erythaematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome Ann Rheum Dis, March 1, 2008; 67(3): 395 - 401. [Abstract] [Full Text] [PDF]